USD 0.63
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 739.52 Thousand USD | 89.45% |
2023 | 390.34 Thousand USD | 556.18% |
2022 | -85.56 Thousand USD | -4644.24% |
2021 | 1883.00 USD | 111.68% |
2020 | -16.12 Thousand USD | 0.0% |
2019 | - USD | 100.0% |
2018 | -641.87 Thousand USD | 13.23% |
2017 | -739.72 Thousand USD | -10.63% |
2016 | -668.63 Thousand USD | 44.37% |
2015 | -1.2 Million USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | 739.52 Thousand USD | 89.45% |
2024 Q1 | 34.91 Thousand USD | 47.64% |
2024 Q2 | 66.45 Thousand USD | 90.33% |
2024 Q4 | 225.35 Thousand USD | -45.41% |
2024 Q3 | 412.8 Thousand USD | 521.2% |
2023 Q4 | 23.64 Thousand USD | -91.74% |
2023 Q3 | 286.42 Thousand USD | 281.28% |
2023 Q2 | 75.12 Thousand USD | 1357.53% |
2023 Q1 | 5154.00 USD | 112.38% |
2023 FY | 390.34 Thousand USD | 556.18% |
2022 Q2 | 4977.00 USD | 649.34% |
2022 FY | -85.56 Thousand USD | -4644.24% |
2022 Q1 | -906.00 USD | 82.13% |
2022 Q3 | -47.99 Thousand USD | -1064.3% |
2022 Q4 | -41.64 Thousand USD | 13.22% |
2021 Q2 | 4440.00 USD | 121.34% |
2021 Q1 | 2006.00 USD | 118.87% |
2021 FY | 1883.00 USD | 111.68% |
2021 Q3 | 507.00 USD | -88.58% |
2021 Q4 | -5070.00 USD | -1100.0% |
2020 FY | -16.12 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | 3845.00 USD | 0.0% |
2020 Q3 | -1645.00 USD | -142.78% |
2020 Q4 | -10.63 Thousand USD | -546.32% |
2019 Q1 | - USD | 100.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | - USD | 100.0% |
2018 FY | -641.87 Thousand USD | 13.23% |
2018 Q4 | -2163.00 USD | -200.0% |
2018 Q3 | 2163.00 USD | 561.47% |
2018 Q1 | 1183.00 USD | 2528.89% |
2018 Q2 | 327.00 USD | -72.36% |
2017 FY | -739.72 Thousand USD | -10.63% |
2017 Q1 | 2009.00 USD | 0.0% |
2017 Q4 | 45.00 USD | -97.92% |
2017 Q3 | 2163.00 USD | -25.59% |
2017 Q2 | 2907.00 USD | 44.7% |
2016 Q1 | 75 Thousand USD | 106.24% |
2016 FY | -668.63 Thousand USD | 44.37% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | -100.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | -1.2 Million USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | -1.2 Million USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acutus Medical, Inc. | -3.13 Million USD | 123.574% |
Cerus Corporation | 86.4 Million USD | 99.144% |
OrthoPediatrics Corp. | 111.25 Million USD | 99.335% |
Talis Biomedical Corporation | 371 Thousand USD | -99.333% |
Vivos Therapeutics, Inc. | 8.27 Million USD | 91.059% |
Inogen, Inc. | 126.69 Million USD | 99.416% |
Spectral AI, Inc. | 7.88 Million USD | 90.615% |
Nano-X Imaging Ltd. | -6.59 Million USD | 111.219% |
CVRx, Inc. | 33.03 Million USD | 97.762% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
Helius Medical Technologies, Inc. | 61 Thousand USD | -1112.338% |
Orthofix Medical Inc. | 486.27 Million USD | 99.848% |
Venus Concept Inc. | 52.16 Million USD | 98.582% |
Accelerate Diagnostics, Inc. | 2.55 Million USD | 70.999% |
Bioventus Inc. | 328.19 Million USD | 99.775% |
BrainsWay Ltd. | 23.09 Million USD | 96.797% |
Envoy Medical, Inc. | -473 Thousand USD | 256.348% |
electroCore, Inc. | 13.22 Million USD | 94.409% |
IceCure Medical Ltd | 1.3 Million USD | 43.113% |
Lucid Diagnostics Inc. | -6.05 Million USD | 112.224% |
Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1662.291% |
MaxCyte, Inc. | 36.54 Million USD | 97.976% |
NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -61.993% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -769.417% |
PAVmed Inc | -3.96 Million USD | 118.637% |
Rapid Micro Biosystems, Inc. | -5.48 Million USD | 113.483% |
RxSight, Inc. | 53.76 Million USD | 98.625% |
Sight Sciences, Inc. | 69.17 Million USD | 98.931% |
SI-BONE, Inc. | 109.42 Million USD | 99.324% |
TELA Bio, Inc. | 40.11 Million USD | 98.156% |
TriSalus Life Sciences, Inc. | 15.9 Million USD | 95.351% |
Treace Medical Concepts, Inc. | 151.93 Million USD | 99.513% |
LivaNova PLC | 771.25 Million USD | 99.904% |
908 Devices Inc. | 25.32 Million USD | 97.08% |
Alphatec Holdings, Inc. | 310.2 Million USD | 99.762% |
Nemaura Medical Inc. | -1.47 Million USD | 150.09% |
NeuroPace, Inc. | 48.12 Million USD | 98.463% |
LENSAR, Inc. | 21.1 Million USD | 96.496% |
Apyx Medical Corporation | 14.12 Million USD | 94.763% |
Cutera, Inc. | 41.49 Million USD | 98.218% |
STRATA Skin Sciences, Inc. | 18.46 Million USD | 95.994% |
BioSig Technologies, Inc. | 18 Thousand USD | -4008.478% |
Anika Therapeutics, Inc. | 103.08 Million USD | 99.283% |
ClearPoint Neuro, Inc. | 13.61 Million USD | 94.568% |
Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.917% |
Axonics, Inc. | 274.55 Million USD | 99.731% |
Outset Medical, Inc. | 29 Million USD | 97.45% |
IRIDEX Corporation | 21.8 Million USD | 96.609% |
PROCEPT BioRobotics Corporation | 71.04 Million USD | 98.959% |
IRadimed Corporation | 50.15 Million USD | 98.526% |
Tivic Health Systems, Inc. | 287 Thousand USD | -157.675% |
INVO Bioscience, Inc. | 1.08 Million USD | 31.912% |
Telesis Bio, Inc. | 16.95 Million USD | 95.637% |
Viemed Healthcare, Inc. | 112.78 Million USD | 99.344% |
Varex Imaging Corporation | 256.9 Million USD | 99.712% |
Quipt Home Medical Corp. | 163.84 Million USD | 99.549% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 282.149% |
Pulmonx Corporation | 50.75 Million USD | 98.543% |
Dynatronics Corporation | 7.63 Million USD | 90.314% |
Modular Medical, Inc. | -768 Thousand USD | 196.292% |
ReShape Lifesciences Inc. | 5.54 Million USD | 86.67% |
Semler Scientific, Inc. | 61.2 Million USD | 98.792% |
InMode Ltd. | 411.34 Million USD | 99.82% |
Bruker Corporation | 1.51 Billion USD | 99.951% |
Cytosorbents Corporation | 22.39 Million USD | 96.697% |
DexCom, Inc. | 2.28 Billion USD | 99.968% |
Align Technology, Inc. | 2.71 Billion USD | 99.973% |
Viveve Medical, Inc. | 620 Thousand USD | -19.278% |
ZimVie Inc. | 290.38 Million USD | 99.745% |
Movano Inc. | -158 Thousand USD | 568.054% |
Cytek Biosciences, Inc. | 109.42 Million USD | 99.324% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -769.417% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.799% |
Profound Medical Corp. | 4.51 Million USD | 83.617% |
Insulet Corporation | 1.15 Billion USD | 99.936% |
enVVeno Medical Corporation | -546 Thousand USD | 235.444% |
Surmodics, Inc. | 93.05 Million USD | 99.205% |
iCAD, Inc. | 14.53 Million USD | 94.912% |
Nuwellis, Inc. | 4.98 Million USD | 85.159% |
Biotricity, Inc. | 8.35 Million USD | 91.15% |
iRhythm Technologies, Inc. | 331.8 Million USD | 99.777% |
Aethlon Medical, Inc. | -359.05 Thousand USD | 305.963% |
InspireMD, Inc. | 1.8 Million USD | 59.074% |
PAVmed Inc. | -3.96 Million USD | 118.637% |
BIOLASE, Inc. | 16.72 Million USD | 95.578% |
Beyond Air, Inc. | -1.3 Million USD | 156.582% |
FONAR Corporation | 45.14 Million USD | 98.362% |
AxoGen, Inc. | 127.87 Million USD | 99.422% |
Vivani Medical, Inc. | -357 Thousand USD | 307.15% |
Tactile Systems Technology, Inc. | 195.13 Million USD | 99.621% |
Inari Medical, Inc. | 434.56 Million USD | 99.83% |
UFP Technologies, Inc. | 112.22 Million USD | 99.341% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 12.51 Thousand USD | -5807.229% |
Tenon Medical, Inc. | 1.24 Million USD | 40.409% |
Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1012.995% |
Co-Diagnostics, Inc. | 2.62 Million USD | 71.85% |
AdaptHealth Corp. | 479.56 Million USD | 99.846% |
Sintx Technologies, Inc. | 1.84 Million USD | 59.874% |
NanoVibronix, Inc. | 1.53 Million USD | 51.885% |
Quanterix Corporation | 70.64 Million USD | 98.953% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 282.149% |
Sensus Healthcare, Inc. | 14.06 Million USD | 94.74% |
Pacific Biosciences of California, Inc. | 52.78 Million USD | 98.599% |
TransMedics Group, Inc. | 154.09 Million USD | 99.52% |
ReWalk Robotics Ltd. | 4.45 Million USD | 83.393% |
NeuroMetrix, Inc. | 3.94 Million USD | 81.266% |
Hyperfine, Inc. | 4.75 Million USD | 84.454% |
Establishment Labs Holdings Inc. | 106.97 Million USD | 99.309% |
Biomerica, Inc. | 611 Thousand USD | -21.035% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 41.68 Million USD | 98.226% |
Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 194.695% |
Silk Road Medical, Inc | 127.08 Million USD | 99.418% |